COVID-19 pneumonia: Correlations between bacterial co-infections, clinical and radiological parameters

Authors

  • Diana GUTSANU Public Medical-Sanitary Institution “Toma Ciorbă” https://orcid.org/0000-0003-1853-6420
  • Lidia PLĂCINTĂ Nicolae Testemitanu State University of Medicine and Pharmacy https://orcid.org/0000-0001-9969-867X
  • Gheorghe PLACINTA Nicolae Testemitanu State University of Medicine and Pharmacy; Public Medical-Sanitary Institution “Toma Ciorbă”

DOI:

https://doi.org/10.52692/1857-0011.2025.2-82.03

Keywords:

bacterial co-infections, COVID-19, inflammatory markers, Brixia score

Abstract

The COVID-19 pandemic created a global health crisis, affecting millions of individuals.After the onset of respiratory symptoms and the identification of viral DNA, the evaluation of patients with COVID-19 includes radiological examinations, the disease extension can be estimated through scores corresponding to the percentage of expansion of pulmonary opacities. The aim of the research was to evaluate the correlation between bacterial co-infections, laboratory parameters and the degree of lung damage expressed by the Brixia score in the context of COVID-19 disease. We conducted a prospective study that included 144 adult patients diagnosed with COVID-19 by Ag or RT-PCR test. On chest X-ray, pneumonia was established in 78.5% of cases, the predominant radiological changes being the accentuated pulmonary pattern with presence of “ground glass” opacities (53.5%). Bacterial associations were isolated in 35.7%, the Chi-square test result demonstrating a weak and statistically insignificant association in relation with the degree of lung damage (χ2 = 1.818, p = 0.178). Hematological parameters, C-reactive protein and ferritin did not demonstrate significant correlations, only band neutrophils showed an increasing trend according to the Brixia score, but a weak one (ρ = 0.348, p = 0.009). Regarding the level of procalcitonin, the results are statistically insignificant (ρ = -0.001, p = 0.998). Bacterial co-infections, isolated in over a third of cases, did not demonstrate a correlation with the degree of lung damage. The severity of lung damage is not associated with hematological and inflammatory parameters, only band neutrophils showed a slight increase trend according to the Brixia score.

References

WHO Director-General’s Opening Remarks at the Media Briefing—5 May 2023. Disponibil online: https://www.who.int/ (accesat 20 mai 2025).

Jovanoski N, Chen X, Becker U, Zalocusky K, Chawla D, Tsai L, et al. Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database. BMJ Open. 2021; 11:e056284.

Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022; 23:194–202.

Nalbandian A, Desai AD, Wan EY. Post-COVID-19 Condition. Annu Rev Med. 2023; 74:55–64.

Ai T, Yang Z, Hou H. Correlation of chest CT and RT- PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; 200642.

Hosseiny M, et al. Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. AJR Am J Roentgenol 214, 1078–1082 (2020).

Wong HYF, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology 296, E72–E78 (2020).

Dennie C, et al. Canadian Association of Thoracic Radiology/Canadian Association of Radiologists Consensus Statement Regarding Chest Imaging in Suspected and Confirmed COVID-19. Can Assoc Radiol J 71, 470–481 (2020).

Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology, 295 (3) (2020), Article 200463.

Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology, 295 (3) (2020), pp. 715-721.

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol (2020).

Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to. COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging (2020).

Hani C, Trieu NH, Saab I, COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging. 2020 May; 101:263-268.

Protocol Clinic Național “ Infecția cu coronavirus de tip nou (Covid-19)”, ediția VIII. Chișinău, 2023.

Choi H, Qi X, Yoon SH, Park SJ, Lee KH, Kim KY, et al. Extension of Coronavirus Disease 2019 (COVID-19) on Chest CT and Implications for Chest Radiograph Interpretation. Radiology: Cardiothoracic Imaging, 2 (2) (2020).

Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P. Cytokine storm: The primary determinant for the pathophysiological evolution of COVID-19 deterioration. Front. Immunol. 2021, 12, 589095.

Sayit AT, Elmali M, Deveci A, Gedikli O. Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia. Rev. Inst. Med. Trop. São Paulo 2021, 63, e51.

Sîrbu AC, Farcaș AD, Bocsan IC, Neag MA, Vesa ȘC, Suciu ȘM, Buzoianu AD. Biomarker Patterns and Their Association with Lung Injury in COVID-19 Patients. Medicina. 2025; 61(5):931.

Published

2026-03-26

Issue

Section

Research Article

Categories